Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 42, 2008, Pages 16224-16229

  Leary, Rebecca J ^a   Lin, Jimmy C ^a   Cummins, Jordan ^a   Boca, Simina ^a,b   Wood, Laura D ^a   Parsons, D Williams ^a   Jones, Siân ^a   Sjöblom, Tobias ^a   Park, Ben Ho ^a   Parsons, Ramon ^c   Willis, Joseph ^d   Dawson, Dawn ^d   Willson, James K V ^e   Nikolskaya, Tatiana ^f,g   Nikolsky, Yuri ^g   Kopelovich, Levy ^h   Papadopoulos, Nick ^a   Pennacchio, Len A ⁱ   Wang, Tian Li ^a   Markowitz, Sanford D ^d   Parmigiani, Giovanni ^a,b   Kinzler, Kenneth W ^a   Vogelstein, Bert ^a   Velculescu, Victor E ^a   more..

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

^g GeneGo bioinformatics software Inc   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ DOE JOINT GENOME INSTITUTE   (United States)

Author keywords

Amplification; Copy number changes; Digital Karyotyping; High density SNP arrays; Homozygous deletion

Indexed keywords

DNA; SIGNAL PEPTIDE;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CELL ADHESION; CELL CYCLE REGULATION; COLORECTAL CANCER; GENE AMPLIFICATION; GENE DELETION; GENE IDENTIFICATION; GENE NUMBER; GENE SEQUENCE; HUMAN; HUMAN CELL; MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR CELL;

BREAST NEOPLASMS; COLORECTAL NEOPLASMS; GENE AMPLIFICATION; GENE DELETION; HOMOZYGOTE; SIGNAL TRANSDUCTION;

EID: 55849099654     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0808041105     Document Type: Article

References (41)

1. Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10:789-799.
2. Bardelli A, Velculescu VE (2005) Mutational analysis of gene families in human cancer. Curr Opin Genet Dev 15:5-12.
3. Strausberg RL, Levy S, Rogers YH (2008) Emerging DNA sequencing technologies for human genomic medicine. Drug Discov Today 13:569-577.
4. Greenman C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446:153-158.
5. Wood LD, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113.
6. Slamon DJ, et al. (1987) Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182.
7. Collins S, Groudine M (1982) Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature 298:679-681.
8. Kamb A, et al. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
9. Li J, et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947.
10. Steck PA, et al. (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362.
11. Hahn SA, et al. (1996) Dpc4, a Candidate Tumor Suppressor Gene At Human Chromosome 18q21.1. Science 271:350-353.
12. Pinkel D, Albertson DG (2005) Array comparative genomic hybridization and its applications in cancer. Nat Genet 37 Suppl:S11-7.
13. Camps J, et al. (2008) Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. Cancer Res 68:1284-1295.
14. Weir BA, et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450:893-898.
15. Haverty PM, et al. (2008) High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer 47:530-542.
16. Mullighan CG, et al. (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446:758-764.
17. Harada T, et al. (2008) Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays. Oncogene 27:1951-1960.
18. Stark M, Hayward N (2007) Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Cancer Res 67:2632-2642.
19. Nagayama K, et al. (2007) Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution. Genes Chromosomes Cancer 46:1000-1010.
20. Zhao X, et al. (2005) Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res 65:5561-5570.
21. Jones S, et al. (2008) Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci USA 105:4283-4288.
22. Cairns P, et al. (1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 11:210-212.
23. Liggett WH, Jr, Sidransky D (1998) Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 16:1197-1206.
24. Wang TL, et al. (2002) Digital karyotyping. Proc Natl Acad Sci USA 99:16156-16161.
25. Steemers FJ, et al. (2006) Whole-genome genotyping with the single-base extension assay. Nat Methods 3:31-33.
26. Peiffer DA, et al. (2006) High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 16:1136-1148.
27. Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK (2006) A high-resolution survey of deletion polymorphism in the human genome. Nat Genet 38:75-81.
28. Sebat J, et al. (2004) Large-scale copy number polymorphism in the human genome. Science 305:525-528.
29. Volik S, et al. (2003) End-sequence profiling: Sequence-based analysis of aberrant genomes. Proc Natl Acad Sci USA 100:7696-7701.
30. Bignell GR, et al. (2007) Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. Genome Res 17:1296-1303.
31. Sjöblom T, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274.
32. Wang Z, et al. (2004) Three classes of genes mutated in colorectal cancers with chromosomal instability. Cancer Res 64:2998-3001.
33. Yu JS, et al. (2008) PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer. Oncogene 27:4657-4665.
34. Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T (2007) Pathway mapping tools for analysis of high content data. Methods Mol Biol 356:319-350.
35. Subramanian A, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545-15550.
36. Collins FS, Barker AD (2007) Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies. Sci Am 296:50-57.
37. Popescu NC (2003) Genetic alterations in cancer as a result of breakage at fragile sites. Cancer Lett 192:1-17.
38. Tanner M, et al. (2006) Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401. J Clin Oncol 24:2428-2436.
39. Coon JS, et al. (2002) Amplification and overexpression of topoisomerase IIalpha predict response to anthracycline-based therapy in locally advanced breast cancer. Clin Cancer Res 8:1061-1067.
40. Varshavsky A (2007) Targeting the absence: Homozygous DNA deletions as immutable signposts for cancer therapy. Proc Natl Acad Sci USA 104:14935-14940.
41. Leary RJ, Cummins J, Wang TL, Velculescu VE (2007) Digital karyotyping. Nat Protoc 2:1973-1986.